Delivery Order SPE2DB22D9362-SPE2DB23FT0BL
Award Date 7/5/23
Potential Completion Date 7/26/23
Potential Value $7.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Funding is provided by DLA in support of Department of Defense requirements. The order has a period of performance from August 1, 2023 through August 22, 2023 and...
- The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 29, 2023. The Defense Logistics Agency will provide funding for this order placed under an undisclosed multiple award contract vehicle. No...
- The Defense Logistics Agency (DOD) awarded a $1,407 delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 133 MG/10 ML vials. DMS Pharmaceutical will deliver 10 mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension, to a location in Park Ridge, Illinois. The firm fixed price order has a period of performance from August 23, 2023 to September 14, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is...
- The Defense Logistics Agency awarded a $9,952 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 28, 2023 to support DOD requirements. No set aside designation or subcontractors were identified. The DLA manages the global supply chain for the Department of Defense,...
- The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to various Department of Defense components. DMS Pharmaceutical will deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a facility in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $10,000 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Performance will take place between March 2nd and March 23rd, 2023. The Defense Logistics Agency manages the Department of Defense's global...
- The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML vials. Under this order, DMS Pharmaceutical will deliver 20 mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 27, 2023 in support of Department of Defense requirements. No set aside designation or subcontractors were identified. This order was issued against an...
- The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML vials. Under this order, DMS Pharmaceutical will provide 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to support the Department of Defense's medical supply needs. The place of performance for order fulfillment is Park Ridge, Illinois. The period of performance is September 8, 2023 through September 29,...
- The Defense Logistics Agency awarded a $3,390 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DLA will receive 10 ML vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension used for postsurgical analgesia, for use in supporting Department of Defense programs. Performance will occur in Park Ridge, Illinois over a three-week period concluding in late August. No set aside provisions or subcontractors were identified....
- The Defense Logistics Agency awarded a $14,928.66 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to various Department of Defense components. DMS Pharmaceutical will deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a facility in Park Ridge,...